Skip Ribbon Commands
Skip to main content

Find a Doctor

Dr Goh Xue Ying

Photo of Dr Goh Xue Ying
Designations:
  • Consultant, Department of Otolaryngology - Head & Neck Surgery, National University Hospital
Qualifications:
MBBS(S'pore), MRCS(Ireland), MMed(ORL), FAMS(ORL)
Specialties:
Otolaryngology - Head & Neck Surgery
Sub-specialties:
Otology/Neuro-otology

Biosketch

Dr. Goh obtained his medical degree from the Yong Loo Lin School of Medicine, National University of Singapore in 2010. He started his residency training the ACGME-I accredited National University Health System ENT residency program in 2012. He obtained the postgraduate qualifications of Member of the Royal College of Surgeons (Ireland) in 2012, as well as the Masters of Medicine in Otolaryngology-Head and Neck Surgery in 2014. He completed his residency training in 2017, serving as the National ENT Chief Resident in his final year of training.

Dr. Goh is currently appointed a Consultant in the Department of Otolaryngology – Head and Neck Surgery, National University Hospital, Singapore.

Dr. Goh is trained in all aspects of the surgical and medical management of general Otolaryngology-Head and Neck Surgery conditions and has a special interest in managing diseases of the ear and hearing restoration.

In the area of research, Dr. Goh's research interests are varied and include research into optimal monitoring of obstructive sleep apnea (OSA) patients after surgery as well as prognostic factors affecting management of thyroid cancers, and has presented in multiple local, regional and international conferences.

Besides performing clinical work, Dr. Goh is active in teaching and mentoring of medical students and junior doctors, and firmly believes in the Hope for a Better Age.

Awards

  • ​2019 - ENT Poster Presentation Winners - 2nd (18th Asean ORL-HNS Congress 2019)

Journals & Publications

1. Chan SL, Ng LS, Goh X, Siow CH, Goh HL, Goh BC, Cheo T, Loh KS, Brunham LR. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.  Head Neck. 2018 Jul;40(7):1425-1433. doi: 10.1002/hed.25112. Epub 2018 Feb 16.
2. Goh X, Lum J, Yang SP, Chionh SB, Koay E, Chiu L, Parameswaran R, Ngiam KY, Loh TKS, Nga ME, Lim CM.  BRAF mutation in papillary thyroid cancer-Prevalence and clinical correlation in a South-East Asian cohort.  Clin Otolaryngol. 2019 Mar;44(2):114-123. doi: 10.1111/coa.13238. Epub 2018 Nov 28.
3. Goh X, Ting Y, Nga ME, Lim LC, Lim CM.  Diagnostic thyroid lobectomy versus active surveillance in the management of Bethesda class III thyroid nodules.  Asian J Surg. 2020 Nov;43(11):1108-1109. doi: 10.1016/j.asjsur.2020.08.002. Epub 2020 Sep 29.

Professional Memberships

  • ​Fellow of academy of medicine (otorhinolaryngology) 


Back to Top